top of page

ABOUT ALZYN

Alzyn9.png
As we age, our digestive system becomes less and less efficient at absorbing critical nutrients your brain needs, leading to cognitive decline and memory loss.
 

Our brain health deserves protection.
 

Introducing: Alzyn*

Alzyn11.png
*Developed and Tested at  Florida State University College of Medicine
MARKET & KEY PLAYERS

  • There is No Cure for Alzheimer's disease (AD)

  • Current medications for AD are called cholinesterase inhibitors and they are Razadyne® (galantamine), Exelon® (rivastigmine), and Aricept® (donepezil)

  • These drugs may help reduce some physical symptoms and help control some behavioral symptoms

  • Biogen’s new monoclonal antibody (mAb) aducanumab is likely to be approved by FDA for the treatment of AD in 2021. It will not cure but slow down the progression of AD at approx. $150,000/yr.

  • Alzyn has been shown in laboratory models to slow the progression of the disease at a fraction of the cost

bottom of page